|
Market Closed -
Japan Exchange
12:00:00 23/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6,350.00 JPY | +0.41% |
|
-1.67% | -20.06% |
Company Valuation: COSMOS Pharmaceutical Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,83,107 | 5,25,081 | 5,02,890 | 7,00,001 | 4,76,495 | 5,03,283 | - | - |
| Change | - | 8.69% | -4.23% | 39.2% | -31.93% | 5.62% | - | - |
| Enterprise Value (EV) 1 | 4,50,132 | 4,97,354 | 4,77,918 | 6,92,920 | 4,76,495 | 5,37,683 | 5,40,702 | 5,46,233 |
| Change | - | 10.49% | -3.91% | 44.99% | -31.23% | 12.84% | 0.56% | 1.02% |
| P/E | 20.9x | 22.1x | 20.6x | 22.6x | 14.9x | 15.7x | 14.8x | 13.9x |
| PBR | 2.54x | 2.49x | 2.17x | 2.72x | 1.68x | 1.63x | 1.5x | 1.38x |
| PEG | - | 7.98x | 7.61x | 0.8x | 4.32x | 56.66x | 2.4x | 2.14x |
| Capitalization / Revenue | 0.64x | 0.63x | 0.52x | 0.69x | 0.43x | 0.43x | 0.4x | 0.37x |
| EV / Revenue | 0.6x | 0.6x | 0.5x | 0.69x | 0.43x | 0.46x | 0.43x | 0.4x |
| EV / EBITDA | 10x | 10.5x | 9.29x | 11.1x | 7.12x | 7.59x | 7.12x | 6.72x |
| EV / EBIT | 15.1x | 16.5x | 15.2x | 17.1x | 11.3x | 12.1x | 11.5x | 10.8x |
| EV / FCF | -39.1x | 93.5x | -222x | -807x | -20.6x | -68.1x | -186x | -862x |
| FCF Yield | -2.56% | 1.07% | -0.45% | -0.12% | -4.85% | -1.47% | -0.54% | -0.12% |
| Dividend per Share 2 | 40 | 50 | 60 | 70 | 82 | 85.3 | 90.01 | 94.2 |
| Rate of return | 0.66% | 0.75% | 0.95% | 0.79% | 1.36% | 1.34% | 1.42% | 1.48% |
| EPS 2 | 292.4 | 300.5 | 308.6 | 390.9 | 404.3 | 405.5 | 430.4 | 458.4 |
| Distribution rate | 13.7% | 16.6% | 19.4% | 17.9% | 20.3% | 21% | 20.9% | 20.6% |
| Net sales 1 | 7,55,414 | 8,27,697 | 9,64,989 | 10,11,390 | 10,99,583 | 11,75,556 | 12,63,383 | 13,63,477 |
| EBITDA 1 | 44,906 | 47,496 | 51,425 | 62,633 | 66,929 | 70,861 | 75,956 | 81,252 |
| EBIT 1 | 29,796 | 30,128 | 31,501 | 40,404 | 42,353 | 44,406 | 47,189 | 50,384 |
| Net income 1 | 23,155 | 23,797 | 24,454 | 30,978 | 32,046 | 32,143 | 34,123 | 36,324 |
| Net Debt 1 | -32,975 | -27,727 | -24,972 | -7,081 | - | 34,400 | 37,419 | 42,950 |
| Reference price 2 | 6,100.00 | 6,630.00 | 6,345.00 | 8,832.00 | 6,012.00 | 6,350.00 | 6,350.00 | 6,350.00 |
| Nbr of stocks (in thousands) | 79,198 | 79,198 | 79,258 | 79,257 | 79,257 | 79,257 | - | - |
| Announcement Date | 11/07/22 | 10/07/23 | 12/07/24 | 11/07/25 | 13/07/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.66x | 0.46x | 7.59x | 1.34% | 320.96Cr | |
| 17.04x | 0.7x | 10.38x | -.--% | 1.53TCr | |
| 23.58x | 0.98x | 10.61x | 1.91% | 703.93Cr | |
| 17.07x | 0.76x | 7.93x | 2.19% | 658.17Cr | |
| 21.05x | 0.36x | 5.64x | 2.17% | 644.18Cr | |
| 19.76x | 0.72x | 12.44x | 1.1% | 590.56Cr | |
| 16.3x | 1.02x | 7.13x | 2.59% | 460.95Cr | |
| 13.93x | 0.59x | 4.53x | 5.19% | 310.06Cr | |
| 14.97x | 0.89x | 6.68x | 4.33% | 302.36Cr | |
| 15.76x | 0.33x | 5.23x | 1.39% | 298.11Cr | |
| Average | 17.51x | 0.68x | 7.82x | 2.22% | 581.85Cr | |
| Weighted average by Cap. | 18.08x | 0.70x | 8.64x | 1.68% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3349 Stock
- Valuation COSMOS Pharmaceutical Corporation
Select your edition
All financial news and data tailored to specific country editions
